Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Mosquito-Lethal Effects of Ivermectin Combinations
NCT02568098Phase 1Completed
- Sponsor
- University of Oxford
- Start
- Oct 2015
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of ivermectin in malaria (3 arms), sponsored by University of Oxford. Primary endpoint: Number of Participants with Adverse Events at 1.5 year. Started Oct 2015; status: completed.
02
Drugs
ivermectin
03
Conditions
malaria
Beyond the preview
Go deeper on NCT02568098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02568098.